research use only

Levoglucosan

Cat.No.S3319

Levoglucosan (LG, LEV, Leucoglucosan, Glucosan, 1,6-anhydro-b-D-Glucose) is an endogenous metabolite.

Levoglucosan Chemical Structure

Chemical Structure

Molecular Weight: 162.14

Quality Control

Batch: S331901 DMSO]32 mg/mL]false]Water]32 mg/mL]false]Ethanol]32 mg/mL]false Purity: 99.17%
99.17

Chemical Information, Storage & Stability

Molecular Weight 162.14 Formula

C6H10O5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 498-07-7 -- Storage of Stock Solutions

Synonyms LG, LEV, Leucoglucosan, Glucosan, 1,6-anhydro-b-D-Glucose Smiles OC1C(O)C2COC(O2)C1O

Solubility

In vitro
Batch:

DMSO : 32 mg/mL ( (197.36 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 32 mg/mL

Ethanol : 32 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06404632 Recruiting
Life Style|Health-Related Behavior|Disabilities Mental|Disability Physical|Acceptability of Health Care
Region Stockholm|Karolinska Institutet|Promobilia Foundation
April 12 2024 Not Applicable
NCT06372301 Recruiting
Transthyretin Amyloid Cardiomyopathy|Aortic Stenosis
Steen Hvitfeldt Poulsen|Aarhus University Hospital Skejby
April 2 2024 Not Applicable
NCT04941599 Recruiting
Familial Hypercholesterolemia
Vanderbilt University Medical Center|National Heart Lung and Blood Institute (NHLBI)
February 14 2024 Phase 2
NCT06130787 Recruiting
LeukemiaMyeloid Chronic
University Hospital Clermont-Ferrand
November 17 2023 Not Applicable
NCT06040164 Not yet recruiting
PreDiabetes|Diabetes Mellitus Type 2|Obesity|Oral Dysbiosis|Mouth Disease
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
October 1 2023 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.